Probability of pancreatic cancer following diabetes: a population-based study

Area of Science:

• Oncology
• Endocrinology
• Epidemiology

Background:

• Diabetes mellitus is a known comorbidity of pancreatic cancer.
• The diagnostic value of new-onset diabetes as an early marker for pancreatic cancer remains unclear.

Purpose of the Study:

• To investigate the association between new-onset diabetes and the subsequent diagnosis of pancreatic cancer.
• To determine the risk of pancreatic cancer in individuals aged 50 and older newly diagnosed with diabetes.

Main Methods:

• A population-based cohort of 2122 individuals aged 50+ with new-onset diabetes was assembled.
• Pancreatic cancer incidence was compared to expected rates using the Iowa Surveillance Epidemiology and End Results registry.
• A nested case-control study examined body mass index and smoking status in relation to pancreatic cancer development.

Main Results:

• 0.85% of the cohort developed pancreatic cancer within 3 years of their diabetes diagnosis; 56% were diagnosed within 6 months.
• The observed-to-expected ratio for pancreatic cancer was 7.94.
• Pancreatic cancer patients were more likely to be diagnosed with diabetes after age 69, but BMI and smoking status did not show statistically significant differences.

Conclusions:

• New-onset diabetes in individuals aged 50 and older is associated with a nearly 8-fold increased risk of pancreatic cancer.
• About 1% of this population will be diagnosed with pancreatic cancer within 3 years of new-onset diabetes.
• Further research is needed to establish the utility of new-onset diabetes as a screening marker for early pancreatic cancer.